Bioengineering, Designing and Editing of Exosomes: Next Generation Reprogramming of Cells and Exosomes

Dear Colleagues,

Exosomes are important transporters of genes, RNAs, microRNAs, proteins, and lipids. They are involved in major diseases including cancer, cardiovascular diseases, neurological disorders, and diabetes mellitus. The delivery of exosomes to recipient cells is governed by the functional heterogeneity of tissues. Engineered exosomes are promising tools for potential use in tissue regeneration. In addition to their role as cargos for intracellular communication, exosomes are increasingly being used as standard biomarkers during the progression of diseases, thereby solving a diagnostic dilemma. Exosomes derived from stem cells have also been widely studied for their ability to promote regeneration and reconstruction of multiple tissues as “cell-free” therapies.

Dr. Mujib Ullah
Guest Editor

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.